41 Results

People

  1. Sadelain
    Sadelain
  2. Dobrin
    Dobrin
  3. Eyquem
    Eyquem
  4. Zhao
    Zhao
  5. Giavridis
    Giavridis
  6. Feucht
    Feucht
  7. Hamieh
    Hamieh
  8. Odak
    Odak
  9. van der Stegen
    van der Stegen
  10. Jain
    Jain

Groups

  1. Center for Hematologic Malignancies (41)
  2. Department of Medicine (41)
  3. GSK Faculty (41)
  4. Hematologic Malignancies Research (41)
  5. Hematologic Malignancies, Division of (41)
  6. MSK Grad Students (41)
  7. Molecular Pharmacology and Chemistry Program Faculty (41)
  8. Sloan Kettering Institute Faculty (41)
  9. Sloan Kettering Institute Postdocs (33)
  10. Alumni (GSK) (19)
  1. "Hematologic Malignancies Research"
  2. "Center for Hematologic Malignancies"
  3. "Michel Sadelain"
  4. "MSK Grad Students"
Formats
  1. Meeting Abstract (22)
  2. Journal Article (17)
  3. Research Letter (1)
  4. Review (1)
Groups
  1. Center for Hematologic Malignancies (41)
  2. Department of Medicine (41)
  3. GSK Faculty (41)
  4. Hematologic Malignancies Research (41)
  5. Hematologic Malignancies, Division of (41)
  6. MSK Grad Students (41)

More Groups

People
  1. Michel Sadelain (41)
  2. Anton Dobrin (15)
  3. Justin Eyquem (14)
  4. Jorge Mansilla-Soto (13)
  5. Zeguo Zhao (13)
  6. Mohamad Hamieh (11)

More People

Years
  1. 2024 (1)
  2. 2023 (7)
  3. 2022 (7)
  4. 2021 (6)
  5. 2020 (6)
  6. 2019 (7)

More Years

Publications
  1. Blood (9)
  2. Molecular Therapy (7)
  3. Nature (6)
  4. Nature Medicine (5)
  5. Cancer Research (4)
  6. Journal for ImmunoTherapy of Cancer (2)

More Publications

Publishers
  1. Nature Publishing Group (19)
  2. American Society of Hematology (9)
  3. American Association for Cancer Research (5)
  4. American Association for the Advancement of Science (2)
  5. Biomed Central Ltd (2)
  6. Cell Press (1)

More Publishers

Results (41)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Disruption of SUV39H1-mediated H3K9 methylation sustains CAR T-cell function
    Journal Article

    Jain, N.; Zhao, Z.; Koche, R. P.; Antelope, C.; Gozlan, Y.; Montalbano, A.; Brocks, D.; Lopez, M.; Dobrin, A.; Shi, Y.; more...
    Cancer Discovery (2024)

    Fulltext@MSK | Save
  • A phase II trial of prophylactic anakinra to prevent neurotoxicity in patients receiving anti-CD19 CAR T-cell therapy for relapsed or refractory lymphoma: Final results from cohort 2
    Meeting Abstract

    Nath, K.; Devlin, S. M.; Sauter, C. S.; Palomba, M. L.; Shah, G. L.; Dahi, P. B.; Lin, R. J.; Scordo, M.; Perales, M. A.; Leslie, L. A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Synthetic dual-costimulation for TCR and TCR-like targeted cell therapies
    Meeting Abstract

    Dobrin, A.; Xie, H.; Perica, K.; Jain, N.; Sadelain, M.; Hamieh, M.
    Human Gene Therapy (2023)

    Fulltext@MSK | Save
  • CD19 CAR T-cell therapy and prophylactic anakinra in relapsed or refractory lymphoma: Phase 2 trial interim results
    Journal Article

    Park, J. H.; Nath, K.; Devlin, S. M.; Sauter, C. S.; Palomba, M. L.; Shah, G.; Dahi, P.; Lin, R. J.; Scordo, M.; Perales, M. A.; more...
    Nature Medicine (2023)

    Fulltext@MSK | Save
  • Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer
    Journal Article

    Rojas, L. A.; Sethna, Z.; Soares, K. C.; Olcese, C.; Pang, N.; Patterson, E.; Lihm, J.; Ceglia, N.; Guasp, P.; Chu, A.; more...
    Nature (2023)

    Fulltext@MSK | Save
  • Novel extragenic genomic safe harbors for precise therapeutic T-cell engineering
    Journal Article

    Odak, A.; Yuan, H.; Feucht, J.; Cantu, V. A.; Mansilla-Soto, J.; Kogel, F.; Eyquem, J.; Everett, J.; Bushman, F. D.; Leslie, C. S.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • TET2 guards against unchecked BATF3-induced CAR T cell expansion
    Journal Article

    Jain, N.; Zhao, Z.; Feucht, J.; Koche, R.; Iyer, A.; Dobrin, A.; Mansilla-Soto, J.; Yang, J.; Zhan, Y.; Lopez, M.; more...
    Nature (2023)

    Fulltext@MSK | Save
  • The ectonucleotidase CD39 identifies tumor-reactive CD8(+) T cells predictive of immune checkpoint blockade efficacy in human lung cancer
    Journal Article

    Chow, A.; Uddin, F. Z.; Liu, M.; Dobrin, A.; Nabet, B. Y.; Mangarin, L.; Lavin, Y.; Rizvi, H.; Tischfield, S. E.; Quintanal-Villalonga, A.; more...
    Immunity (2023)

    Fulltext@MSK | Save
  • SUV39H1 disruption enhances the persistence and anti-tumor efficacy of CD28-costimulated human CAR T cells
    Meeting Abstract

    Jain, N.; Zhao, Z.; Koche, R.; Gozlan, Y.; Brocks, D.; Raveh-Sadka, T.; Wells, D.; Dobrin, A.; Shi, Y.; Lopez, M.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Neoantigen quality predicts immunoediting in survivors of pancreatic cancer
    Journal Article

    Łuksza, M.; Sethna, Z. M.; Rojas, L. A.; Lihm, J.; Bravi, B.; Elhanati, Y.; Soares, K.; Amisaki, M.; Dobrin, A.; Hoyos, D.; more...
    Nature (2022)

    Fulltext@MSK | Save